Sollis Therapeutics Inc — Form D
Sollis Therapeutics Inc of COLUMBUS, OH, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-25. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-25
- Form: D
- Accession: 0001739483-20-000003
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 3
- Date of first sale: 2020-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-374029
Issuer
- Name: Sollis Therapeutics Inc
- CIK: 0001739483
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1275 KINNEAR ROAD, COLUMBUS, OH, 43212
- Phone: 614-636-4971
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Alex DiNello | Executive Officer | Hilliard, OH |
Other filings by this issuer (1)
More